Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SLGL Stock Forecast 2025-2026
$42.30
Current Price
$117.84M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to SLGL Price Targets
+18.2%
To High Target of $50.00
+18.2%
To Median Target of $50.00
+18.2%
To Low Target of $50.00
SLGL Price Momentum
+3.9%
1 Week Change
+32.7%
1 Month Change
+727.8%
1 Year Change
+354.8%
Year-to-Date Change
-19.1%
From 52W High of $52.26
+952.2%
From 52W Low of $4.02
📊 TOP ANALYST CALLS
Did SLGL Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Sol-Gel is one of their latest high-conviction picks.
Latest SLGL Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, SLGL has a bullish consensus with a median price target of $50.00 (ranging from $50.00 to $50.00). The overall analyst rating is N/A (N/A/10). Currently trading at $42.30, the median forecast implies a 18.2% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Raghuram Selvaraju at HC Wainwright & Co., projecting a 18.2% upside. Conversely, the most conservative target is provided by Raghuram Selvaraju at HC Wainwright & Co., suggesting a 18.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SLGL Analyst Ratings
1
Buy
0
Hold
0
Sell
SLGL Price Target Range
Low
$50.00
Average
$50.00
High
$50.00
Current: $42.30
Latest SLGL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SLGL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 27, 2025 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $50.00 |
| Aug 19, 2024 | Raymond James | Elliot Wilbur | Outperform | Downgrade | $4.00 |
| May 22, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $6.00 |
| May 20, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $6.00 |
| Nov 13, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $9.00 |
| Aug 14, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $12.00 |
| Aug 11, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $7.00 |
| Jul 24, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Jul 19, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $9.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Apr 12, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Mar 14, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $10.00 |
| Feb 1, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Nov 14, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $19.00 |
| Nov 11, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $13.00 |
| Oct 21, 2022 | Jefferies | Glen Santangelo | Hold | Initiates | $5.50 |
| Aug 29, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $22.00 |
| May 16, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $16.00 |
| Apr 25, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $21.00 |
| Apr 1, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $17.00 |
Sol-Gel Technologies Ltd. (SLGL) Competitors
The following stocks are similar to Sol-Gel based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sol-Gel Technologies Ltd. (SLGL) Financial Data
Sol-Gel Technologies Ltd. has a market capitalization of $117.84M with a P/E ratio of -11.1x. The company generates $18.97M in trailing twelve-month revenue with a -47.4% profit margin.
Revenue growth is -92.5% quarter-over-quarter, while maintaining an operating margin of -1,572.0% and return on equity of -29.6%.
Valuation Metrics
Market Cap
$117.84M
Enterprise Value
$93.06M
P/E Ratio
-11.1x
PEG Ratio
0.0x
Price/Sales
6.0x
Growth & Margins
Revenue Growth (YoY)
-92.5%
Gross Margin
N/A
Operating Margin
-1,572.0%
Net Margin
-47.4%
EPS Growth
-92.5%
Financial Health
Cash/Price Ratio
+17.7%
Current Ratio
5.2x
Debt/Equity
4.2x
ROE
-29.6%
ROA
-16.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Sol-Gel Technologies Ltd. (SLGL) Business Model
About Sol-Gel Technologies Ltd.
What They Do
Pharmaceutical company specializing in dermatological treatments.
Business Model
Sol-Gel Technologies generates revenue by developing and commercializing topical dermatology products for common skin conditions such as acne and rosacea. Utilizing its proprietary aerosol-based drug-delivery platform and nanotechnology, the company enhances drug efficacy and patient experience, allowing for a competitive edge in the market.
Additional Information
Founded in 1997 and headquartered in Israel, Sol-Gel is committed to research and development and actively seeks collaborations and partnerships to expand its product offerings and market presence in the dermatology therapeutics industry.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
34
CEO
Mr. Moshe Arkin
Country
Israel
IPO Year
2007
Website
www.sol-gel.comSol-Gel Technologies Ltd. (SLGL) Latest News & Analysis
Latest News
Quick Summary
Sol-Gel Technologies plans to seek high-frequency BCC indication for SGT-610, potentially doubling its market potential. The company also secured Health Canada approval for EPSOLAY and an agreement with Viatris for Australia and New Zealand.
Why It Matters
Sol-Gel's pursuit of high-frequency BCC for SGT-610 could significantly enhance its market potential, reflecting growth opportunities and potential revenue increases for investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel Technologies completed patient enrollment for its Phase-3 trial of SGT-610 for Gorlin Syndrome, with results expected Q4 2026. They also announced a $16 million deal for EPSOLAY and TWYNEO.
Why It Matters
Completion of patient enrollment in a Phase-3 trial and ongoing trials signal progress for Sol-Gel's products, potentially impacting future revenue and market position. Cash runway extension enhances financial stability.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Sol-Gel Reports First Quarter 2025 Results
6 months ago
Quick Summary
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) reported its financial results for Q1 2025, ending March 31. Further details on the results were not provided in the excerpt.
Why It Matters
Sol-Gel Technologies' Q1 financial results can indicate its growth potential and clinical progress, impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Sol-Gel Announces Reverse Share Split
7 months ago
Quick Summary
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) announced a 10-for-1 reverse share split, consolidating its ordinary shares, effective May 1, 2025.
Why It Matters
A reverse share split often signals an effort to boost a company's stock price and attract institutional investors, affecting liquidity and market perception of Sol-Gel Technologies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel will receive $16 million in 2025, extending its cash runway into Q1 2027. It has achieved over 80% patient recruitment for its SGT-610 Phase III trial, with results expected Q4 2026.
Why It Matters
Sol-Gel's $16 million funding and extended cash runway enhance its ability to complete pivotal trials, potentially unlocking significant market value with SGT-610, estimated at $400-$500 million annually.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A new market intelligence report highlights innovative technologies and emerging opportunities in the global surface engineering industry, projecting changes through 2035.
Why It Matters
Emerging technologies and opportunities in the surface engineering industry could lead to significant investment returns and influence market dynamics through 2035.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SLGL Stock
What is Sol-Gel Technologies Ltd.'s (SLGL) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Sol-Gel Technologies Ltd. (SLGL) has a median price target of $50.00. The highest price target is $50.00 and the lowest is $50.00.
Is SLGL stock a good investment in 2026?
According to current analyst ratings, SLGL has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $42.30. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SLGL stock?
Wall Street analysts predict SLGL stock could reach $50.00 in the next 12 months. This represents a 18.2% increase from the current price of $42.30. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Sol-Gel Technologies Ltd.'s business model?
Sol-Gel Technologies generates revenue by developing and commercializing topical dermatology products for common skin conditions such as acne and rosacea. Utilizing its proprietary aerosol-based drug-delivery platform and nanotechnology, the company enhances drug efficacy and patient experience, allowing for a competitive edge in the market.
What is the highest forecasted price for SLGL Sol-Gel Technologies Ltd.?
The highest price target for SLGL is $50.00 from Raghuram Selvaraju at HC Wainwright & Co., which represents a 18.2% increase from the current price of $42.30.
What is the lowest forecasted price for SLGL Sol-Gel Technologies Ltd.?
The lowest price target for SLGL is $50.00 from Raghuram Selvaraju at HC Wainwright & Co., which represents a 18.2% increase from the current price of $42.30.
What is the overall SLGL consensus from analysts for Sol-Gel Technologies Ltd.?
The overall analyst consensus for SLGL is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $50.00.
How accurate are SLGL stock price projections?
Stock price projections, including those for Sol-Gel Technologies Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 11, 2025 4:07 AM UTC